Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA OKs First Drug for Agitation in Alzheimer's Dementia

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation